el-Hassan A M, Zijlstra E E
Department of Immunology and Clinical Pathology, Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
Trans R Soc Trop Med Hyg. 2001 Apr;95 Suppl 1:S19-26. doi: 10.1016/s0035-9203(01)90217-2.
Sudanese mucosal leishmaniasis is a chronic infection of the upper respiratory tract and/or oral mucosa caused mainly by Leishmania donovani. The disease occurs in areas of the country endemic for visceral leishmaniasis, particularly among Masalit and other closely related tribes in western Sudan. The condition may develop during or after an attack of visceral leishmaniasis, but in most cases it is a primary mucosal disease. Unlike South American mucocutaneous leishmaniasis, mucosal leishmaniasis in Sudan is not preceded or accompanied by a cutaneous lesion. Pathologically, the lesions show a mixture of macrophages, plasma cells and lymphocytes. An epithelioid granuloma may also be found. Parasites are scanty. Diagnosis is established by demonstration of parasites in smears or biopsies, by culture or animal inoculation, or with the aid of the polymerase chain reaction. Most patients give positive results in the direct agglutination test and leishmanin skin test. Patients respond well to treatment with pentavalent antimony compounds.
苏丹黏膜利什曼病是一种主要由杜氏利什曼原虫引起的上呼吸道和/或口腔黏膜的慢性感染。该病发生在该国内脏利什曼病的流行地区,特别是在苏丹西部的马萨利特族和其他关系密切的部落中。这种情况可能在内脏利什曼病发作期间或之后出现,但在大多数情况下它是一种原发性黏膜疾病。与南美黏膜皮肤利什曼病不同,苏丹的黏膜利什曼病之前或同时不会出现皮肤病变。病理上,病变表现为巨噬细胞、浆细胞和淋巴细胞的混合。也可能发现上皮样肉芽肿。寄生虫数量稀少。通过在涂片或活检中发现寄生虫、培养或动物接种,或借助聚合酶链反应来确诊。大多数患者在直接凝集试验和利什曼原虫素皮肤试验中呈阳性结果。患者对五价锑化合物治疗反应良好。